Verfahren und System zur Nukleinsäuresequenzierung
Anmelder: Siemens Healthcare GmbH 🇩🇪
Details
- Veröffentlichungs-Nr.
- EP3409788
- Aktenzeichen
- EP17174059
- Anmeldetag
- 1. Juni 2017
- Veröffentlichung
- 6. Januar 2021
- Erteilung
- 6. Januar 2021
- Rechtsraum
- EP
- IPC
- C12Q1/6869
Abstract
The present invention relates to methods and systems for nucleic acid sequencing. In particular, the present invention relates to methods and systems for reducing the number of false-positives in nucleic acid sequencing. The method comprises: aligning a plurality of genetic reads to a reference genetic sequence; grouping the genetic reads into a plurality of groups; creating a consensus sequence for each group of the plurality of groups by setting a representation of the most abundant nucleotide man_p or a tag N based on a ratio r; and identifying a variation as a true variation if a ratio r* between the number of consensus sequences comprising the tag N at a specific position p and the number of the consensus sequences comprising the variation at the specific position p is below a threshold t*.
Anmelder
- Firma
- Siemens Healthcare GmbH
- Land
- 🇩🇪 Deutschland
Deutsches Unternehmen mit Sitz in Erlangen, frühere Gesundheitssparte des Siemens-Konzerns. Entwickelte medizinische Bildgebungssysteme, Diagnostik und Laborlösungen für Kliniken und Praxen.
3.598 Patente in unserer Datenbank
Fachgebiete
Vertreten von
Kein Vertreter erfasst.